Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
Acute Back Pain Global Clinical Trials Review, H1, 2014
Publication Date May 2014
Product Type Report
Pages 58
Single User License help $ 2500.00
Site User License help $ 5000.00
Corporate User License help $ 7500.00
 

Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase.

Acute Back Pain Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Acute Back Pain Global Clinical Trials Review, H1, 2014" provides data on the Acute Back Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Back Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acute Back Pain. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Acute Back Pain 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Acute Back Pain to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Acute Back Pain to Central Nervous System Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Acute Back Pain Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Merck & Co., Inc. 28
Clinical Trial Overview of Merck & Co., Inc. 28
Lincoln Pharmaceuticals Ltd 29
Clinical Trial Overview of Lincoln Pharmaceuticals Ltd 29
Endo International plc 30
Clinical Trial Overview of Endo International plc 30
DAEWON PHARM. CO.LTD. 31
Clinical Trial Overview of DAEWON PHARM. CO.LTD. 31
Boehringer Ingelheim GmbH 32
Clinical Trial Overview of Boehringer Ingelheim GmbH 32
BiRDS Pharma GmbH 33
Clinical Trial Overview of BiRDS Pharma GmbH 33
Clinical Trial Overview of Top Institutes / Government 34
Shahrekord University of Medical Sciences 34
Clinical Trial Overview of Shahrekord University of Medical Sciences 34
Luton & Dunstable Hospital NHS Foundation Trust 35
Clinical Trial Overview of Luton & Dunstable Hospital NHS Foundation Trust 35
The American British Cowdray Medical Center, I.A.P. 36
Clinical Trial Overview of The American British Cowdray Medical Center, I.A.P. 36
Qom University of Medical Science and Health Services 37
Clinical Trial Overview of Qom University of Medical Science and Health Services 37
Shanghai Center for Disease Control and Prevention 38
Clinical Trial Overview of Shanghai Center for Disease Control and Prevention 38
Danish Working Environment Authority 39
Clinical Trial Overview of Danish Working Environment Authority 39
The Queen Elizabeth Hospital 40
Clinical Trial Overview of The Queen Elizabeth Hospital 40
The Tel Aviv Sourasky Medical Center 41
Clinical Trial Overview of The Tel Aviv Sourasky Medical Center 41
Brooke Army Medical Center 42
Clinical Trial Overview of Brooke Army Medical Center 42
The University of Hong Kong 43
Clinical Trial Overview of The University of Hong Kong 43
Five Key Clinical Profiles 44
Appendix 56
Abbreviations 56
Definitions 56
Research Methodology 57
Secondary Research 57
About GlobalData 58
Contact Us 58
Disclaimer 58
Source 58

List of Tables
List of Tables
Acute Back Pain Therapeutics, Global, Clinical Trials by Region, 2014* 7
Acute Back Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Acute Back Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Acute Back Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Acute Back Pain Therapeutics Clinical Trials, Europe, Top Countries, 2014* 11
Acute Back Pain Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Acute Back Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Acute Back Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Acute Back Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Acute Back Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Acute Back Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Acute Back Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Acute Back Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Acute Back Pain Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Acute Back Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Acute Back Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Acute Back Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Acute Back Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Acute Back Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Acute Back Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Acute Back Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Acute Back Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 28
Acute Back Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Lincoln Pharmaceuticals Ltd, 2014* 29
Acute Back Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo International plc, 2014* 30
Acute Back Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by DAEWON PHARM. CO.LTD., 2014* 31
Acute Back Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2014* 32
Acute Back Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by BiRDS Pharma GmbH, 2014* 33
Acute Back Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahrekord University of Medical Sciences, 2014* 34
Acute Back Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Luton & Dunstable Hospital NHS Foundation Trust, 2014* 35
Acute Back Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by The American British Cowdray Medical Center, I.A.P., 2014* 36
Acute Back Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Qom University of Medical Science and Health Services, 2014* 37
Acute Back Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Center for Disease Control and Prevention, 2014* 38
Acute Back Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Danish Working Environment Authority, 2014* 39
Acute Back Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by The Queen Elizabeth Hospital, 2014* 40
Acute Back Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by The Tel Aviv Sourasky Medical Center, 2014* 41
Acute Back Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Brooke Army Medical Center, 2014* 42
Acute Back Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2014* 43

List of Figures
List of Figures
Acute Back Pain Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Acute Back Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Acute Back Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Acute Back Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Acute Back Pain Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 11
Acute Back Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Acute Back Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Acute Back Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Acute Back Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Acute Back Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Acute Back Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Acute Back Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Acute Back Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Acute Back Pain Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Acute Back Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Acute Back Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Acute Back Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Acute Back Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Acute Back Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Acute Back Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Acute Back Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 57

Title Date Price
Europe Digital Camera Head for Endoscopes Industry 2016 Market Research Report
By QYResearch
The Europe Digital Camera Head for Endoscopes Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Digital Camera Head for Endoscopes industry. The re ...Read More
Apr 2016 $3600.00
China Pharmaceutical Guidebook Series (4) Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medicines
By Access China Management Consulting Ltd
The traditional medicines in Orient, especially, the traditional Chinese medicines are always regarded by occidental as mysterious medicines. Until today not only the chemical composition of tradition ...Read More
May 2015 $750.00
Latest Guide to Chinese Pharmaceutical GMP Regulations
By Access China Management Consulting Ltd
China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2012, sales on the Chinese drug market have reached RMB 926.1billion (about US$147 billion) ...Read More
Jul 2015 $750.00
"Acne vulgaris "- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acne vulgaris  - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the disease and ...Read More
Apr 2016 $4950.00
"Acute coronary syndrome(ACS)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute coronary syndrome (ACS) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of th ...Read More
Apr 2016 $4950.00
"Acute heart failure(AHF)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute heart failure (AHF) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the di ...Read More
Apr 2016 $4950.00
"Acute ischemic stroke (AIS)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute ischemic stroke (AIS) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the ...Read More
Apr 2016 $4950.00
"Acute lymphoblastic leukemia (ALL)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute lymphoblastic leukemia (ALL) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview ...Read More
Apr 2016 $4950.00
"Age-related macular degeneration (AMD)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Age-related macular degeneration (AMD) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overv ...Read More
Apr 2016 $4950.00
"Alzheimer’s disease (AD)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Alzheimer’s disease (AD) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the d ...Read More
Apr 2016 $4950.00

  * Required field
Name *
E-mail *
Telephone 
Company *
Country *
Query 
 
   

Published By :  GlobalData

For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9893555190
 
 
To receive alerts about
an update, future offers and discounts on this report, signup here.
Email ID
 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z